Found: 3
Select item for more details and to access through your institution.
The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 11, p. 2220, doi. 10.1038/leu.2013.54
- By:
- Publication type:
- Article
A novel arsenical has antitumor activity toward As<sub>2</sub>O<sub>3</sub>-resistant and MRP1/ABCC1-overexpressing cell lines.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
- Published in:
- 2008
- By:
- Publication type:
- journal article